PuSH - Publication Server of Helmholtz Zentrum München: Assays for insulin and insulin-like metabolic activity based on hepatocytes, myocytes and diaphragms.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Müller, G.

Assays for insulin and insulin-like metabolic activity based on hepatocytes, myocytes and diaphragms.

In: Drug Discovery and Evaluation: Pharmacological Assays. Cham, Switzerland: Springer, 2016. 2723-2780

DOI

Abstract
Metrics
Extra information

Despite the eminent importance of studies with primary and cultured adipocytes or adipose tissues on the basis of their physiological role in the regulation of lipid and carbohydrate metabolism in humans in combination with the relative low expenditure in preparing adipocytes of high quality and number, compounds and drug candidates for future antidiabetic and antiobesity therapy have to be analyzed for their effects in primary and cultured hepatocytes and myocytes or liver and muscle tissues, too. In principle, the majority of the assays described above for adipocytes can be adapted for the use with hepatocytes and myocytes. However, the following selection takes into account the relative contribution of each process monitored to its role in the whole-body regulation of intermediary metabolism in the normal and disease state. Moreover, technical aspects, such as requirement for a special equipment and applicability in throughput screening assays for drug discovery, were additional criteria.

Altmetric